Ingrid Sarmiento

1.2k total citations
21 papers, 907 citations indexed

About

Ingrid Sarmiento is a scholar working on Pharmacology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Ingrid Sarmiento has authored 21 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Infectious Diseases and 5 papers in Molecular Medicine. Recurrent topics in Ingrid Sarmiento's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Antibiotic Resistance in Bacteria (5 papers). Ingrid Sarmiento is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Antibiotic Resistance in Bacteria (5 papers). Ingrid Sarmiento collaborates with scholars based in United States, Canada and Colombia. Ingrid Sarmiento's co-authors include Francis F. Arhin, Greg Moeck, Thomas Parr, Geoffrey A. McKay, Adam Belley, Sylvain Beaulieu, Esteban V. Cardemil, Kathryn A. Martin, Staci A. Gruber and Janet E. Hall and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Ingrid Sarmiento

21 papers receiving 858 citations

Peers

Ingrid Sarmiento
Sandra Ribes Germany
Mark Guy United Kingdom
Myungsun Lee South Korea
H. I. Miller United States
Jiaqi Zou China
Zhilu Xu Hong Kong
Ingrid Sarmiento
Citations per year, relative to Ingrid Sarmiento Ingrid Sarmiento (= 1×) peers Hidehito Matsui

Countries citing papers authored by Ingrid Sarmiento

Since Specialization
Citations

This map shows the geographic impact of Ingrid Sarmiento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Sarmiento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Sarmiento more than expected).

Fields of papers citing papers by Ingrid Sarmiento

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Sarmiento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Sarmiento. The network helps show where Ingrid Sarmiento may publish in the future.

Co-authorship network of co-authors of Ingrid Sarmiento

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Sarmiento. A scholar is included among the top collaborators of Ingrid Sarmiento based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Sarmiento. Ingrid Sarmiento is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arhin, Francis F., Ingrid Sarmiento, & Greg Moeck. (2014). In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene. International Journal of Antimicrobial Agents. 44(1). 65–68. 13 indexed citations
2.
Sylvia, Louisa G., Carrie Brown, Paula I. Martin, et al.. (2012). An Adjunct Exercise Program for Serious Mental Illness: Who Chooses to Participate and is it Feasible?. Community Mental Health Journal. 49(2). 213–219. 4 indexed citations
4.
Arhin, Francis F., Ingrid Sarmiento, Thomas Parr, & Greg Moeck. (2011). Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus. International Journal of Antimicrobial Agents. 39(2). 159–162. 11 indexed citations
5.
Belley, Adam, Geoffrey A. McKay, Francis F. Arhin, et al.. (2010). Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing. Antimicrobial Agents and Chemotherapy. 54(12). 5369–5371. 96 indexed citations
6.
Tanaka, Kelly S.E., Evelyne Dietrich, Stéphane Ciblat, et al.. (2010). Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis. Bioorganic & Medicinal Chemistry Letters. 20(4). 1355–1359. 25 indexed citations
7.
Arhin, Francis F., Adam Belley, Geoffrey A. McKay, et al.. (2010). Assessment of Oritavancin Serum Protein Binding across Species. Antimicrobial Agents and Chemotherapy. 54(8). 3481–3483. 16 indexed citations
8.
Cardemil, Esteban V., Tatiana M. Davidson, Ingrid Sarmiento, et al.. (2010). Developing a Culturally Appropriate Depression Prevention Program: Opportunities and Challenges. Cognitive and Behavioral Practice. 17(2). 188–197. 12 indexed citations
9.
McKay, Geoffrey A., Sylvain Beaulieu, Francis F. Arhin, et al.. (2009). Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 63(6). 1191–1199. 114 indexed citations
10.
Arhin, Francis F., Geoffrey A. McKay, Sylvain Beaulieu, et al.. (2009). Time–kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes. International Journal of Antimicrobial Agents. 34(6). 550–554. 16 indexed citations
11.
Arhin, Francis F., Geoffrey A. McKay, Sylvain Beaulieu, et al.. (2009). Impact of human serum albumin on oritavancin in vitro activity against Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 65(2). 207–210. 4 indexed citations
12.
Sarmiento, Ingrid & Esteban V. Cardemil. (2009). Family Functioning and Depression in Low‐Income Latino Couples. Journal of Marital and Family Therapy. 35(4). 432–445. 66 indexed citations
13.
McKay, Geoffrey A., Sylvain Beaulieu, Ingrid Sarmiento, et al.. (2009). Impact of Human Serum Albumin on Oritavancin In Vitro Activity against Enterococci. Antimicrobial Agents and Chemotherapy. 53(6). 2687–2689. 15 indexed citations
14.
Dietrich, Evelyne, Tom J. Houghton, Francis F. Arhin, et al.. (2008). Bisphosphonated Benzoxazinorifamycin Prodrugs for the Prevention and Treatment of Osteomyelitis. ChemMedChem. 3(12). 1863–1868. 21 indexed citations
15.
Tanaka, Kelly S.E., Tom J. Houghton, Ting Kang, et al.. (2008). Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis. Bioorganic & Medicinal Chemistry. 16(20). 9217–9229. 36 indexed citations
16.
Arhin, Francis F., Ingrid Sarmiento, Adam Belley, et al.. (2008). Effect of Polysorbate 80 on Oritavancin Binding to Plastic Surfaces: Implications for Susceptibility Testing. Antimicrobial Agents and Chemotherapy. 52(5). 1597–1603. 92 indexed citations
17.
Houghton, Tom J., Kelly S.E. Tanaka, Ting Kang, et al.. (2008). Linking Bisphosphonates to the Free Amino Groups in Fluoroquinolones: Preparation of Osteotropic Prodrugs for the Prevention of Osteomyelitis. Journal of Medicinal Chemistry. 51(21). 6955–6969. 65 indexed citations
18.
Joffe, Hadine, Janet E. Hall, Staci A. Gruber, et al.. (2006). Estrogen therapy selectively enhances prefrontal cognitive processes. Menopause The Journal of The North American Menopause Society. 13(3). 411–422. 184 indexed citations
19.
McKay, Geoffrey A., Francis F. Arhin, Adam Belley, et al.. (2005). Triaminotriazine DNA helicase inhibitors with antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 16(5). 1286–1290. 45 indexed citations
20.
Gören, Jessica L., et al.. (2004). Bioavailability and Lack of Toxicity of S‐Adenosyl‐l‐Methionine (SAMe) in Humans. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(11). 1501–1507. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026